Assertio and Garda delay tender offer launch to May 14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% as AI buildout costs, Fed rate outlook weigh
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Assertio and Garda Mutually Agree to Delay Launch of Tender Offer
May 8, 2026 8:00 AM EDTLAKE FOREST, Ill.--(BUSINESS WIRE)-- Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (Garda) to delay the launch of the previously announced tender offer to acquire all outstanding shares of Assertio to May 14, 2026.
As previously announced on May 4, 2026, Assertio has entered into an amended and restated merger agreement (the Garda Agreement) to be acquired by Garda for $21.80 per share in cash, or total cash consideration of $153.2 million. The Company expects to file a Schedule 14D-9 in connection with the tender... More
